Advertisement
Home Tags Food & Drug Administration

Tag: Food & Drug Administration

Extending the market exclusivity for existing drugs that are granted subsequent U.S. Food and Drug Administration approval for a new rare disease indication would provide manufacturers with substantial compensation

Extending Rx Exclusivity Could Boost Study for Rare Diseases

0
Substantial compensation to many drug manufacturers, especially for top-selling products
Trulance has been approved by the U.S. Food and Drug Administration to treat persistent idiopathic constipation in adults.

FDA Approves Trulance for Chronic Idiopathic Constipation

0
Drug designed to stimulate secretion of intestinal fluid
A new U.S. government guideline classifies fish into three categories of safety to help pregnant women

FDA, EPA Issue Guidance on Fish Consumption

0
Recommendations aimed at pregnant women, breastfeeding mothers, parents of young children
The excessive regulatory regime at the U.S. Food and Drug Administration is an important driver of high drug prices

Excessive FDA Regulation Driving High Drug Prices

0
First-in-class drugs are fast-tracked while follow-on drugs can take up to 15 years to be approved
The drug Rubraca (rucaparib) has been granted accelerated approval by the U.S. Food and Drug Administration to treat advanced ovarian cancer.

FDA Grants Fast-Track Approval to Ovarian Cancer Drug

0
Rubraca's use is specific to women with deleterious BRCA mutations
Maci (autologous cultured chondrocytes on porcine collagen membrane) has been approved by the U.S. Food and Drug Administration to repair symptomatic

FDA OKs Autologous Cellularized Scaffold for Knee Cartilage Repair

0
For symptomatic, full-thickness cartilage defects of the knee in adult patients
Intrarosa (prasterone) has been approved by the U.S. Food and Drug Administration to treat women who have moderate-to-severe pain during sexual intercourse caused by postmenopausal vulvar and vaginal atrophy.

FDA Approves Intrarosa for Postmenopausal Pain During Sex

0
Drug contained in a once-daily vaginal insert
The Amplatzer PFO Occluder device has been approved by the U.S. Food and Drug Administration to prevent another stroke among patients who have had at least one prior stroke involving a patent foramen ovale.

FDA Approves Device to Prevent Recurrent Strokes in PFO Patients

0
For patients who had prior stroke related to patent foramen ovale
Supplemental testosterone and related anabolic-androgenic steroids can cause heart attacks

FDA Warns of Testosterone, AAS Abuse and Dependence

0
Many American men take them, but heart and psychological issues can occur, agency says
Lartruvo (olaratumab) has been approved by the U.S. Food and Drug Administration to treat adults with certain soft tissue sarcomas.

FDA Approves New Treatment for Advanced Soft Tissue Sarcoma

0
Sanctioned for use with doxorubicin in cases that cannot be treated with radiation or surgery